Menu

rss
Thorax doi:10.1136/thoraxjnl-2012-202014
  • PostScript
  • Correspondence

Safety of long-acting β-agonists in asthma

  1. Jose A Castro-Rodriguez2
  1. 1Emergency Department, Hospital Central de las Fuerzas Armadas, Montevideo, Uruguay
  2. 2School of Medicine, Pontificia Universidad Catolica de Chile, Las Condes, Santiago, Chile
  1. Correspondence to Dr Gustavo J Rodrigo, Emergency Department, Hospital Central de las Fuerzas Armadas, Uruguay, Av. 8 de Octubre 3020, Montevideo 11300, Uruguay; gurodrig{at}adinet.com.uy
  • Accepted 13 April 2012
  • Published Online First 10 May 2012

The study by Wolfe et al1 certainly does not support our claim that serious asthma exacerbations are more frequent in patients receiving formoterol 24 μg twice daily than in those receiving …

[Full text of this article]

This Article

  1. Extract
  2. Full text
  3. PDF
  4. All Versions of this Article:
    1. thoraxjnl-2012-202014v1
    2. 67/11/1015-a most recent

Social bookmarking


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Thorax.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.